Research Fellow in Epidemiology

Nanyang Technological University - Lee Kong Chian School of Medicine

Lee Kong Chian School of Medicine invites applications for:

Research Fellow in Epidemiology

Lee Kong Chian School of Medicine (LKCMedicine) established in September 2010 is a partnership between Imperial College London and Nanyang Technological University (NTU), Singapore. Consistently rated amongst the world's best universities, Imperial College London is a science-based institution with a reputation for excellence in teaching and research while NTU is the only Singapore university listed in the Top 10 of the Times Higher’s 200 Under 50 Rankings and is ranked the world’s No. 1 young university by QS in the last three consecutive years.

LKCMedicine operates from two campuses – Yunnan Campus at Nanyang Technological University and Novena Campus, which is located in the precinct of the future HealthCity. At LKCMedicine, we recognize that synergies is the key to maximize research output and we seek to promote synergies between researchers in LKCMedicine itself and local and/or overseas researchers. We strongly believe that building synergies and robust collaborations will be the key to maximizing research output in today’s competitive environment.

We are currently recruiting a Research Fellow in Epidemiology to join Professor John C Chambers at LKCMedicine. Professor John C Chambers had been recently awarded the prestigious NMRC STaR Award (Translating ‘omics’ into stratified approach for prevention of type 2 diabetes: TOAST-T2D). The aim of the study is to determine if molecular information can be used to inform stratified approaches for health promotion and therapeutic intervention to prevent type 2 diabetes (T2D). Specific aims for this study include (i) replicating and extending the association of DNA methylation and serum metabolites with incident T2D amongst Singapore Chinese people, (ii) developing, calibrating and validating the molecular risk scores for prediction of T2D, (iii) completing a randomized clinical trial to determine if lifestyle modification and pharmacological intervention reduce risk of T2D compared to standard care in 1500 high-risk people, etc. 

Main responsibilities of the incumbent include (but not limited to):

  • Quality control and analysis of epidemiological data from both observational population studies and from prospective clinical trials conducted in TOAST-T2D, as well as data linkage to health records;
  • Develop and evaluate biomarkers and risk functions for predictions of diabetes, and other major diseases;
  • Study and analyse the causes of diabetes, analyse data to support the implementation of proposed intervention/policy development;
  • Present results within the research group, using appropriate presentations formats;
  • Make a strong contribution to reporting study results, including writing up for publication in peer-reviewed journals and support grant applications;
  • Participate in seminars and work-in-progress meetings within the team and collaborators.

Candidates should have at least PhD in Epidemiology or Public Health. A strong understanding of patterns, causes, and effects of health and disease conditions in defined populations, especially diabetic patients and/or experience with working in clinical research setting or in a healthcare setting would be an advantage. Salary will commensurate with experience and qualifications.

Application Procedure:

Please apply to TOAST-T2D at LKCMedicine ( with names of two referees. Only shortlisted candidates are notified.

Closing date: 28th February 2018       

Share this job
  Share by Email   Print this job   More sharing options
We value your feedback on the quality of our adverts. If you have a comment to make about the overall quality of this advert, or its categorisation then please send us your feedback
Advert information

Type / Role:


Asia & Middle East